Clinicians managing patients with HIV require updated education on pharmacologic considerations that impact treatment safety and efficacy. There is a clear need for enhanced understanding of drug-drug interactions, metabolic and clearance pathways, and the interpretation of laboratory results affected by specific antiretroviral agents. Additionally, practitioners must be aware of alternative antiretroviral formulations and dosing strategies for those who are unable to take oral tablets. This webinar offers practical strategies to improve clinical decision-making and ensure optimal patient outcomes in complex treatment scenarios, and provides an overview of major drug interactions for current antiretroviral therapy drugs such as cabotegravir, lenacapavir, and doravirine.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 131 Steuart St
Pricing
CME included with membership
| On-Demand CME Course Fee | $55 |
Collected from the provider’s public pages · source
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
- Commercial Support
-
ReleasedJan 27, 2026
-
Last day to claim creditJan 28, 2027 4 months left
-
International Antiviral Society-USA (IAS-USA) TAM June/July 2026 Volume 34, Issue 3
-
International Antiviral Society-USA (IAS-USA) Managing ART Options in the Setting of HIV Drug Resistance (On-Demand)
-
International Antiviral Society-USA (IAS-USA) No Mo’ FOMO 2026: In Case You Missed It Recent Changes in Guidelines, New Publications, and Updates From Recent Conferences (On-Demand)
